SmartestCrowd
Projects
No projects
News
Projects
Orgs
Project
Articles 1004
Votes 5
40% interested
MarketWatch
Home
Articles
Authors
91
Mike Murphy
Caroline Baum
Richard Eisenberg
Ciara Linnane
Ciara Linnane
Barbara Kollmeyer
Archie Mitchell
Steve Goldstein
Callum Keown
Lina Saigol
Associated Press
Shawn Langlois
Jon Swartz
Jaimy Lee
Jeffry Bartash
Rupert Steiner
Tomi Kilgore
William Watts
Therese Poletti
Emily Bary
Wallace Witkowski
Jacob Passy
Mark DeCambre
Myra P. Saefong
Christine Idzelis
Andrew Keshner
MarketWatch
Steve Gelsi
Joseph Adinolfi
Nicole Lyn Pesce
Alisa Wolfson
Anviksha Patel
Jamie Chisholm
Clive McKeef
Quentin Fottrell
James Rogers
Vivien Lou Chen
Mark Hulbert
Weston Blasi
Isabel Wang
Danielle Hyams
Jessica Hall
Charles Passy
Philip van Doorn
Frances Yue
Greg Robb
Bill Peters
Joy Wiltermuth
Andrew Shilling
Alessandra Malito
Francine Toder
Claudia Assis
Rebecca Myers
Katie Marriner
Levi Sumagaysay
Cody Willard
Zoe Han
Lauren Thomas
Laura Cooper
Jeremy C. Owens
Brett Arends
Debra Wallace
Anushree Dave
Beth Pinsker
Jonathan Burton
Chris Matthews
Victor Reklaitis
Eleanor Laise
Aarthi Swaminathan
Lawrence G. McMillan
Liz Weston
Nouriel Roubini
Kate Ashford
Leslie Albrecht
Rachel Koning Beals
Morey Stettner
Louis Goss
Ryan Shrout
MarketWatch Automation
Nelson Ireson
Ed Yardeni
Lukas I. Alpert
Robert Schroeder
Genna Contino
Britney Nguyen
Christine Ji
William Gavin
Gordon Gottsegen
Jules Rimmer
Hannah Pedone
1
2
3
4
5
…
Next
»
U.S. stocks have been surprisingly resilient as the Iran conflict threatens global economic disruption. Thank industry analysts? - MarketWatch
1d
Panic is slowly gripping the stock market. Expect the selling to pick up next week. - MarketWatch
4d
Why a 1980s conflict may be the best market analog for the current Iran situation - MarketWatch
5d
11 stocks to harden your portfolio against Iran risk - MarketWatch
6d
Jobless claims show ‘sluggish but generally stable’ labor market - MarketWatch
6d
The chorus of disapproval for private credit gets louder as Morgan Stanley fund is the latest to cap withdrawals - MarketWatch
6d
More pain in private credit with JPMorgan reportedly tightening lending while a $33 billion fund sees heavy redemptions - MarketWatch
7d
This aging expert says this one thing can help your cognitive and physical health - MarketWatch
8d
Return to the 2022 stock-market playbook as Iran conflict drags on, say these strategists - MarketWatch
8d
50 years of oil-price shocks have taught us that only 2 things matter to markets right now - MarketWatch
9d
Dow futures sink more than 1,000 points, oil prices surge up to 30% as Iran conflict rages - MarketWatch
9d
Investors betting on international stocks trouncing the U.S. are getting a rude awakening from the Iran conflict - MarketWatch
13d
Here’s how far oil is away from dragging stocks into a bear market, according to Morgan Stanley - MarketWatch
16d
Why did AI ‘science fiction’ spur market panic? We asked a behavioral-finance expert to find out. - MarketWatch
22d
There’s a vital difference in how Medicare and Medicare Advantage prevent and treat strokes. What you should know. - MarketWatch
22d
Did a blog post just cause software stocks to lose more than $200 billion in market cap? - MarketWatch
23d
U.S. stocks are falling behind. It could be the beginning of an epic shift toward global markets. - MarketWatch
28d
What the 10-year Treasury’s move toward 4% says about AI anxiety in markets - MarketWatch
29d
Stock Market Today: Dow, S&P 500 and Nasdaq set to retreat as tech stocks continue to reel - MarketWatch
29d
Why the ‘HALO’ trade boosting hard assets is no fluke, according to Morgan Stanley - MarketWatch
29d
Apple sees $200 billion market-cap wipeout as stock slides on AI fears - MarketWatch
~1mo
S&P 500 turns negative for 2026 as investors add job market to a growing list of worries facing Wall Street - MarketWatch
~1mo
Why AMD’s stock is diving toward its worst day in years after earnings - MarketWatch
~1mo
Why Apple’s blockbuster earnings weren’t enough to lift the stock - MarketWatch
~2mo
Gold’s soaring so fast it’s topped Goldman target set only last week. Now a JPMorgan analyst plots path to $8,500. - MarketWatch
~2mo
1
2
3
4
5
…
Next
»
Modal title
...
Profile
Loading profile
Loading...